A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A.

MLA

Raschko, J. W., et al. “A Phase I Study of Carboplatin and Etoposide Administered in Conjunction with Dipyridamole, Prochlorperazine and Cyclosporine A.” Cancer Chemotherapy and Pharmacology, vol. 46, no. 5, 2000, pp. 403–10. EBSCOhost, https://doi.org/10.1007/s002800000142.

APA

Raschko, J. W., Synold, T. W., Chow, W., Coluzzi, P., Hamasaki, V., Leong, L. A., Margolin, K. A., Morgan, R. J., Shibata, S. I., Somlo, G., Tetef, M. L., Yen, Y., ter Veer, A., & Doroshow, J. H. (2000). A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A. Cancer Chemotherapy and Pharmacology, 46(5), 403–410. https://doi.org/10.1007/s002800000142

Chicago

Raschko, J W, T W Synold, W Chow, P Coluzzi, V Hamasaki, L A Leong, K A Margolin, et al. 2000. “A Phase I Study of Carboplatin and Etoposide Administered in Conjunction with Dipyridamole, Prochlorperazine and Cyclosporine A.” Cancer Chemotherapy and Pharmacology 46 (5): 403–10. doi:10.1007/s002800000142.